Advertisement

Search Results for "Ctla 4 Expression On Monocytes"

15:28 EDT 25th May 2013 | BioPortfolio

Matching Channels

Cytotoxic lymphocyte associated molecule 4 CTLA 4 CD152

Cytotoxic lymphocyte-associated molecule-4 (CTLA-4, CD152) is a member of the CD28 receptor family which is expressed on the surface of Helper T cells. CTLA-4 is similar to the T-cell costimulatory pr...

Myc is the protein encoded by the MYC gene that activates the cell cycle

Myc is the protein encoded by the MYC gene that activates the cell cycle. It promotes cell replication through genetic coding for p14, inhibiting MDM2 and preventing the degradation of the pro-apopt...

Epigenetics

In biology, and specifically genetics, epigenetics is the study of changes in gene expression caused by mechanisms other than changes in the underlying DNA sequence – hence the name epi- (Gree...

Polo like kinase Plk 1

Polo-like kinase (Plk) is an important cell cycle regulatory kinase that has been implicated in a multitude of cell cycle events. Plks form a family of four different proteins that regulates many as...

Hedgehog signalling cascades

Despite the humorous name, hedgehog signalling cascades are central to embryonic development and has been implicated in the development of a number of diseases, including cancer. The downstream ca...

Matching News

Strategic synergy

NYU researchers have shown that the induction of NKG2D ligands contributes to the synergy of radiotherapy with an anti-CTLA-4 mAb. The findings could be used to identify patients most likely to respon...

Strategic synergy: Figure 1: Nkg2d ligands contribute to the synergy of radiotherapy and anti-CTLA-4 mAbs

Tools: Strategic synergy Figure 1. Nkg2d ligands contribute to the synergy of radiotherapy and anti-CTLA-4 mAbs. In mice with poorly immunogenic murine carcinoma cells treated with an anti-CTLA-4 (CD1...

Changes in monocytes are biomarker for amyotrophic lateral sclerosis

Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Geh...

miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis

Wang and colleagues show that miR-126 and miR-126* suppress metastasis by inhibiting the production of the Sdf-1α cytokine in mouse mammary tumours, resulting in decreased recruitment of mesenchymal...

Blood-circulating monocytes can replace brain resident microglia

The immune system is comprised of multiple cell types each capable of specialized functions to protect the body from invading pathogens and promote tissue repair after injury. One cell type, known as...

A One-Two Punch By The Immune System Knocks Out Cancer Cells

An emerging class of therapies called "checkpoint blockade" enhance the immune system's ability to attack cancer cells by interfering with the immunological checkpoints that slow or stop immune cell a...

The Immunocytokine L19–IL2 Eradicates Cancer When Used in Combination with CTLA-4 Blockade or with L19-TNF

Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer

Matching PubMed Articles

CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions.

Cytotoxic T lymphocyte antigen-4 (CTLA-4) is the major negative regulator of T cell responses although growing evidence supports its wider role as an immune attenuator which may also act in other cell...

Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer.

The role of CTLA-4 in negative regulation of T-cell mediated immune response is particularly well established. Much less is known about its expression and function in tumour cells, and to our knowledg...

CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis.

The aim of this study was to explore whether cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphisms confer susceptibility to Behcet's disease (BD). A meta-analysis was conducted on the associations b...

Low CTLA-4 expression in CD4+ helper T-cells in patients with fulminant type 1 diabetes.

Fulminant type 1 diabetes is a novel subtype of type 1 diabetes characterized by a remarkably abrupt onset of insulin-deficient hyperglycemia. An accelerated immune reaction has been suggested as the...

Dysregulated Expression of Both the Costimulatory CD28 and Inhibitory CTLA-4 Molecules in PB T Cells of Advanced Cervical Cancer Patients Suggests Systemic Immunosuppression Related to Disease Progression.

Cervical cancer (CC) occurs more frequently in women who are immunosuppressed, suggesting that both local and systemic immune abnormalities may be involved in the evolution of the disease. Costimulato...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement